Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Urine
0090368
 
Ordering Recommendation
Mnemonic
CDCO PPXY
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon
Reported
1-7 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Random urine.  
Specimen Preparation
Transfer 4 mL with no additives or preservatives urine to an ARUP Standard Transport Tube. (Min: 1 mL)  
Storage/Transport Temperature
Room temperature.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
 
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years  
Reference Interval
Interpretive Data
Drugs covered: propoxyphene and metabolite (norpropoxyphene - qualitative only)

Positive cutoff:
10 ng/mL

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

For medical purposes only; not valid for forensic use.
Note
CPT Code(s)
83925
Components
Component Test Code*Component Chart Name
0090368Drug Conf, Propoxyphene/Metab, Urine
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Capadex
  • Darvocet
  • Darvon
  • Detropropoxyphene
  • Di-Gesic
  • Digesic
  • Doloxene
  • Norpropoxyphene
  • Pain Management
  • Pain Management, Propoxyphene, Quantitative, with medMATCH, Urine
  • Pain Management, Propoxyphene, with Confirmation with medMATCH, Urine
  • Paradex
  • Propoxyphene
  • Wygesic